CD8A and neoplasm: Furthermore, IL-10 and IL-35 augmented their cooperation to limit antitumor immunity by inducing inhibitory receptors, including PD-1, and contributing to T-cell exhaustion of CD8+-Tregs once the tumor cells recurred, because IL-10 was abundantly secreted by tumor cells in B-cell VRL.